071018 Medicaid key findings

  • Medicaid drug costs grew almost 50 percent per patient from 2008 through 2016, causing the program’s drug spending to nearly double to $31 billion. Such costs are helping drive up Medicaid expenses, which accounted for more than a quarter of 26 states’ budgets in 2016.
  • After a Center for Public Integrity reporter made inquiries, one state Medicaid official divested his stock in pharmaceutical companies and a doctor advising Medicaid drug decisions resigned his position because he failed to disclose payments from drugmakers as required.